Boehringer Ingelheim and BioMed X collaborate to discover new epigenetic regulators of COPD
Heidelberg (ots) - BioMed X announced today that they have entered into a collaboration agreement with Boehringer Ingelheim to establish a research group focusing on the identification of novel therapeutic concepts for treating patients with chronic obstructive pulmonary disease (COPD). Outstanding early career scientists from leading academic institutions world-wide ...